Sarah Bennett
The pneumonia vaccine, also known as the pneumococcal vaccine, is a crucial step in preventing severe illnesses and their complications. Pneumonia is a serious illness that can lead to life-threatening infections in the lungs, blood, and brain. While the vaccine is recommended for infants and those over 50, it is especially crucial for adults aged 65 and above, who are at a higher risk of developing pneumococcal disease. This age group typically requires two pneumococcal shots, while most other individuals generally need one shot for lifelong protection. However, it's important to consult with a healthcare provider to determine the appropriate vaccine schedule based on age, overall health, and risk factors.
| Characteristics | Values |
|---|---|
| Who should get the vaccine? | Infants, adults, and people who are at high risk. |
| High-risk groups | People with weakened immune systems, chronic health conditions, heavy drinkers, and people getting over surgery or severe illness. |
| Age groups | Children younger than 5, adults 50 or older, and adults 65 or older. |
| Number of shots | One to three shots, depending on age and health history. |
| Shot longevity | A pneumonia shot typically lasts for life. |
| Types of vaccines | Pneumococcal conjugate vaccines (PCVs) and PPSV23. |
| Vaccination timing | Pneumonia vaccines can be given at any time of the year. |
| Side effects | Rare but mild and typically go away within one to two days. |
| Allergies | Avoid PCV shots if you've had severe allergies in the past. |
Explore related products
What You'll Learn
Pneumonia vaccine recommendations for infants
Pneumonia is a lower respiratory tract infection that causes coughing, fever, chest pain, and, in severe cases, breathing trouble. Pneumococcal bacteria spread from person to person through respiratory droplets. Depending on which parts of the body become infected, people can experience severe illness, including bacterial meningitis, bacteremia, inflammation, and infection in the protective covering of the brain and spinal cord.
The pneumococcal vaccine, also called the pneumonia vaccine, is an immunization that protects children and adults against many types of pneumococcal bacteria. There are two types of pneumonia vaccines: pneumococcal conjugate types (PCV13, PCV15, and PCV20) protect against 13, 15, and 20 different types of pneumococcal bacteria, respectively, including the ones that most commonly cause infections in children. The pneumococcal polysaccharide vaccine (PPSV23) protects against 23 different types of pneumococcal bacteria.
The CDC recommends pneumococcal vaccination for children younger than 5 years old and adults 50 years or older. The CDC also recommends pneumococcal vaccination for children and adults at increased risk of pneumococcal disease. The CDC recommends a routine pneumococcal vaccination for all infants and children aged 2 to 59 months. Depending on the vaccine(s) given, an additional dose may be recommended for children with high-risk conditions.
The pneumococcal vaccine is recommended for infants in four doses of either PCV13 or PCV15. The pneumococcal vaccine is recommended for children younger than 5 years of age who miss their shots or start the series later than recommended. The number of doses recommended and the intervals between doses will depend on the child's age when vaccination begins. If PCV15 is used, a dose of PPSV23 may be given a year later if needed.
Hep B Vaccine: Who Pays When Employers Require It?
You may want to see also
Explore related products
Pneumonia vaccine recommendations for adults
Pneumonia vaccines are an important part of preventing severe illnesses and their complications. Pneumococcal bacteria, which cause pneumonia, spread from person to person through respiratory droplets. Pneumonia vaccines are recommended for infants, adults, and those who are at high risk. The CDC recommends pneumococcal vaccination for children younger than 5 years old and adults 50 years or older.
For most people, a pneumonia shot will last a lifetime, and only one shot is needed. However, there are two different vaccines, and some people may need both. The type of vaccine and the number of doses depend on age and vaccination history. PCVs are for children aged 5 or younger and adults 65 or older. PPSV23 is for children aged 2 to 18 who have certain medical conditions, as well as adults who've had PCV15 or a previous vaccine called PCV13.
If you are an adult younger than 50 years with a risk condition, you should get a dose of PPSV23, followed by PCV20 or PCV21 at least a year later. If you are an adult aged 19-49 with a weakened immune system, you should get the vaccine. This includes those with heart disease, sickle cell disease, chronic liver disease, diabetes, asthma, or chronic obstructive pulmonary disease (COPD). Heavy drinkers may also have a weakened immune system and should consider getting the vaccine.
If you are an adult aged 65 or older, you may need two shots. You can get PCV20 or PCV21, or choose not to get additional pneumococcal vaccines. If you are getting the vaccine for the first time at 65 or older, you will need two shots, one year apart.
Epstein-Barr Virus: Vaccine Hope or Hype?
You may want to see also
Explore related products
Pneumonia vaccine side effects
In infants, protection from the pneumococcal vaccine lasts only a few months while their bodies build up immunity to the bacteria, which is why multiple doses are given a few months apart. In adults, one to three doses of the pneumococcal vaccine will likely provide lifelong protection.
The CDC recommends pneumococcal vaccination for children younger than 5 years old and adults 50 years or older. The CDC also recommends vaccination for children and adults at increased risk of pneumococcal disease. There are two types of pneumococcal vaccines used in the United States, and each individual vaccine protects against different serotypes of pneumococcal bacteria.
The following side effects may occur and usually do not require medical attention: bleeding, blistering, burning, coldness, discolouration of skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site.
If you experience any side effects that concern you, be sure to notify your doctor.
Influenza Vaccine Options for Seniors Over 65
You may want to see also
Explore related products
Pneumonia vaccine and COVID vaccine
The pneumococcal (pneumonia) vaccine can prevent many severe illnesses, including pneumococcal disease, pneumococcal meningitis, and pneumococcal pneumonia. Pneumococcal bacteria spread from person to person through respiratory droplets. The CDC recommends pneumococcal vaccination for children younger than 5 years and adults 50 years or older. Children between the ages of 2 and 18 may need additional pneumococcal vaccine doses if they have other medical conditions that increase their risk, such as a compromised immune system. Adults 65 years or older have the option to get PCV20 or PCV21, or to forgo additional pneumococcal vaccines. For most people, a single pneumonia shot will last a lifetime. However, some people may need to get two different vaccines.
The COVID-19 vaccine is crucial for controlling severe respiratory diseases. It has been shown to reduce the risk of severe progression of the disease, which can cause serious morbidity and mortality in the elderly and vulnerable populations. The presence of the COVID-19 vaccine was found to be protective against COVID-19 diagnosis and hospitalization, especially in combination with the influenza and pneumococcal vaccines. Studies have shown that it is safe and effective to get the pneumococcal and COVID-19 vaccines together, and they can be administered within a short time of each other.
Pneumococcal vaccination may also provide protection against COVID-19. A preprint study from researchers at the Mayo Clinic reported strong associations between pneumococcal vaccination and protection against COVID-19, especially among minority patients. This may be due to "molecular mimicry," where the immune system mistakes the proteins in the pneumococcal vaccine for proteins produced by the SARS-CoV-2 virus. Broader implementation of pneumococcal vaccination could guard against the worst effects of COVID-19 illness and reduce deaths.
In summary, both the pneumonia vaccine and the COVID-19 vaccine are important for preventing severe respiratory illnesses and their complications. The pneumonia vaccine is recommended for certain age groups and high-risk individuals, while the COVID-19 vaccine is crucial for all eligible individuals to control the spread of the virus and reduce hospitalizations and deaths. The two vaccines can be safely administered together or within a short time of each other.
Vaccine Trials: Placebo and Double-Blind
You may want to see also
Explore related products
Pneumonia vaccine for high-risk groups
Pneumonia vaccines are recommended for infants, adults, and people who are at high risk of contracting pneumococcal disease. Pneumococcal disease is caused by bacteria that commonly live in the nose and throat and can cause mild infections such as ear infections, as well as more serious infections like pneumonia. The vaccine helps protect against different serotypes of pneumococcal bacteria.
The CDC recommends pneumococcal vaccination for children younger than 5 years old and adults 50 years or older. Children between the ages of 2 and 18 years with other medical conditions that increase their risk, such as a compromised immune system from HIV infection or cancer, may also be advised to get vaccinated. Additionally, adults younger than 50 years old may be recommended to receive pneumococcal vaccines based on their risk factors.
For most people, a single pneumonia shot provides lifelong protection. However, some individuals may require additional doses or a different vaccine type. Adults 65 years or older have the option to receive PCV20 or PCV21, or they may choose not to get additional pneumococcal vaccines. Those with certain health conditions, such as immunocompromised illnesses, may also require a second vaccine or additional doses. It is important to consult with a healthcare provider to determine the appropriate vaccine type and dosage based on individual risk factors and health history.
High-risk groups for pneumococcal disease include older adults, immunocompromised individuals, and people with specific underlying conditions. Examples of underlying conditions include chronic heart disease, chronic liver disease, chronic lung disease, cigarette smoking, diabetes mellitus, and certain immunodeficiencies. Individuals who have recently undergone major surgery, suffered a serious injury, or been hospitalized in the intensive care unit with a ventilator are also at increased risk of developing pneumonia.
Tdap Vaccine Ingredients: What's Inside?
You may want to see also
